Marker-based CRISPR screens identify POU2F1 as a regulator of DLL3 and neuroendocrine identity in small cell lung cancer

Cunniff, Patrick J, Fitzpatrick, Connor, Bauer, Jack, Skopelitis, Damianos, Pal, Sujay, Shanley, Liam, Taneja, Kamil, Klingbeil, Olaf, Yoshimoto, Toyoki, Joshua-Tor, Leemor, Vakoc, Christopher R (December 2026) Marker-based CRISPR screens identify POU2F1 as a regulator of DLL3 and neuroendocrine identity in small cell lung cancer. NAR Cancer, 8 (4). zcag032. ISSN 2632-8674 (Public Dataset)

[thumbnail of 10.1093.narcan.zcag032.pdf] PDF
10.1093.narcan.zcag032.pdf - Published Version
Available under License Creative Commons Attribution.

Download (4MB)

Abstract

Small cell lung cancers (SCLCs) often exhibit a neuroendocrine lineage identity marked by high expression of Delta-like ligand 3 (DLL3). Because DLL3 shows minimal expression in normal adult tissues, it serves as an SCLC-selective tumor antigen and is the basis for clinically efficacious targeted therapies. Understanding the mechanisms that regulate DLL3 expression is therefore critical for advancing therapeutic strategies in this disease. Here, we performed transcription factor-focused and genome-wide CRISPR screens to identify regulators of DLL3 expression in SCLC. Both approaches converged on POU2F1 as a top activator of DLL3 in this tumor context. Despite its ubiquitous expression, we identify an SCLC-specific role for POU2F1 in activating DLL3 and a broader set of neuroendocrine lineage genes. Epigenomic analyses reveal tandem POU2F1-ASCL1 motifs within the DLL3 promoter that underlie the functional cooperativity between POU2F1 and the neuroendocrine master regulator ASCL1 for high-level DLL3 expression in SCLC. We provide evidence that tandem POU2F1-ASCL1 elements are part of a cis-regulatory code for the lung neuroendocrine cell fate. Together, these findings define a previously unrecognized transcriptional logic controlling DLL3 expression and establish POU2F1 as a context-specific regulator of neuroendocrine lineage in SCLC.

Item Type: Paper
Subjects: Investigative techniques and equipment > CRISPR
diseases & disorders > cancer
diseases & disorders
Investigative techniques and equipment
Investigative techniques and equipment > CRISPR-Cas9
diseases & disorders > cancer > cancer types > lung cancer
diseases & disorders > cancer > cancer types
CSHL Authors:
Communities: CSHL Cancer Center Program > Cancer Genetics and Genomics Program
CSHL Cancer Center Program > Gene Regulation and Inheritance Program
CSHL labs > Joshua-Tor lab
CSHL labs > Tuveson lab
CSHL labs > Vakoc lab
CSHL labs > Wigler lab
CSHL Cancer Center Program
CSHL Post Doctoral Fellows
School of Biological Sciences > Publications
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: December 2026
Date Deposited: 20 Nov 2026 19:39
Last Modified: 20 Nov 2026 19:39
PMCID: PMC13778627
Related URLs:
Dataset ID:
  • GEO: GSE317998
  • GEO: GSE317997
  • GEO: GSE317996
  • https://genome.ucsc.edu/s/pcunniff/DLL3_POU2F1_ASCL1_H209_hg38
  • https://figshare.com/projects/Marker-based-CRISPR-screens-identify-POU2F1-as-a-regulator-of-DLL3-and-neuroendocrine-identity-in-small-cell-lung-cancer/280107
URI: https://repository.cshl.edu/id/eprint/42373

Actions (login required)

Administrator's edit/view item Administrator's edit/view item